Replies to post #134421 on Biotech Values

[mcbio]

Also AMGN and MRK (#msg-66596860), although the PCSK9 programs are inconsequential to the valuation of those two.

In a strange way, it might be net-positive for ISIS as it presumably lessens a large competitive threat to mipomersen.